Related Experiment Video
Updated: Nov 14, 2025

10:02
State of the Art Cranial Ultrasound Imaging in Neonates
Published on: February 2, 2015
25.2K
Head circumference trajectory in children with perinatal stroke
Amanda Leong1, Amalia Floer1, Adam Kirton1,2
1Calgary Pediatric Stroke Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Journal of Child Neurology
|March 8, 2021
Summary
Children with perinatal stroke experience slower head growth, which is linked to poorer developmental outcomes. Head circumference monitoring may help identify neurological risks early.
Area of Science:
- Pediatric Neurology
- Neurodevelopmental Disorders
- Medical Imaging
Background:
- Perinatal stroke is a primary cause of hemiparetic cerebral palsy and long-term disability.
- Predicting neurodevelopmental outcomes in affected children remains challenging.
- Head circumference deceleration is a known indicator of adverse outcomes in neonatal brain injury.
Purpose of the Study:
- To investigate if perinatal stroke leads to reduced head growth rates in children.
- To determine the association between head growth deceleration and neurodevelopmental outcomes.
Main Methods:
- Utilized data from the Alberta Perinatal Stroke Project cohort.
- Included patients with confirmed neonatal arterial ischemic stroke or presumed perinatal ischemic stroke.
- Analyzed occipital-frontal circumference data against control charts and correlated with Pediatric Stroke Outcome Measures (PSOM) scores.
Main Results:
- Head circumference measurements from 102 patients over a median of 3.2 years were analyzed.
- Occipital-frontal circumference deviated below normal growth trajectories after 3 months (females) and 1 year (males) (P < .05).
- Smaller head circumference was significantly associated with poor outcomes (PSOM ≥ 1) (P < .05).
Conclusions:
- Children with perinatal arterial ischemic stroke exhibit head growth deceleration.
- This deceleration is linked to adverse neurodevelopmental outcomes.
- Head circumference can serve as a potential clinical marker for neurological risk assessment.

